Results 211 to 220 of about 425,151 (292)
Procedural Outcome of Modern Percutaneous Coronary Intervention in Proximal Chronic Total Occlusions
ABSTRACT Background Long‐term outcome in patients with chronic total occlusions (CTO) depends on the target vessel and proximity of the lesion. Aims To investigate of the target vessel was associated with procedural efficacy and safety in patients with proximal CTO lesions.
Emil N. Holck +21 more
wiley +1 more source
Feasibility and early outcomes of single-stage hybrid revascularization for femoroiliac occlusive disease in patients with advanced peripheral arterial disease. [PDF]
Aldag M, Jochmann-Schiek N.
europepmc +1 more source
ABSTRACT This patient is a 77‐year‐old male with non‐ischemic cardiomyopathy, severe tricuspid regurgitation, and moderate mitral regurgitation who underwent simultaneous transcatheter edge‐to‐edge repair of both mitral and tricuspid valves. Post‐procedure, the patient exhibited significant symptomatic improvement and reduced regurgitation severity ...
Omar Khan, Matthew Summers
wiley +1 more source
Association of monocyte-lymphocyte ratio with peripheral arterial disease in US participants: a retrospective cross-sectional study. [PDF]
Liu Q, Wu X, Shi J.
europepmc +1 more source
Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction
ABSTRACT Background Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.
Aamer Ubaid +4 more
wiley +1 more source
Peripheral arterial disease: Gap in the knowledge and awareness of associated risk factors in the general population of Saudi Arabia. [PDF]
Alkhatieb MT +6 more
europepmc +1 more source
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu +9 more
wiley +1 more source
PCSK9 in peripheral arterial disease: Mechanisms and therapeutic perspectives. [PDF]
Gao Y +7 more
europepmc +1 more source
ABSTRACT Background Chronic thromboembolic pulmonary disease (CTEPD) leads to chronic total occlusions (CTOs) of the pulmonary arteries in a minority of patients. Treatment of CTOs with balloon pulmonary angioplasty (BPA) may substantially improve patient hemodynamics but presents unique technical challenges and has previously been associated with a ...
Elliot J. Stein +4 more
wiley +1 more source

